Compare Hims and Hers Health Inc (HIMS) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Thomson Reuters Corp — how do they compare? Hims and Hers Health Inc trades at $30.82 (market cap $6.55B), while Thomson Reuters Corp trades at $103.08 (market cap $43.89B). The key difference: Thomson Reuters Corp is far larger — about 6.7× Hims and Hers Health Inc's market cap, and Thomson Reuters Corp pays a 2.58% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Thomson Reuters Corp for 63 Days on average.
| HIMS | TRI | |
|---|---|---|
Market Cap | $6.55B | $43.89B |
Volume | 14,842,814 | 1,648,199 |
Sector | Health | Industrials |
52-Week High | $62.76 | $163.45 |
52-Week Low | $14.52 | $76.55 |
Typical Hold Time | 21 Days | 63 Days |
Enterprise Value | $7.25B | $46.51B |
Dividend Yield | — | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $30.12, up 1.96% on the day, amid a bearish technical outlook and mixed fundamentals. The stock faces headwinds from a securities class action lawsuit related to an FTC complaint, with multiple law firms alerting investors ahead of a November 2, 2026 deadline. Financially, revenue grew to $2.35 billion in 2025, but net income turned negative in 2026, with a net loss of $142 million and a profit margin of -5.51%. Analyst consensus is a 'Hold' with a $32.17 price target, indicating limited upside from current levels.
The outlook for HIMS is cautious due to legal overhangs and profitability challenges. Investment opportunities hinge on resolving regulatory issues and returning to earnings growth, but risks include prolonged litigation, competitive pressures, and execution missteps. The stock's high valuation multiples, such as a P/E of 57.14, add vulnerability if growth disappoints.
Thomson Reuters (TRI) trades at $103.21, up 3.96% today, showing strong momentum near resistance at $103. The stock maintains robust fundamentals with 10% organic growth in core businesses and a 21.22% net income margin. Recent strategic moves include divesting the printing unit to focus on technology and launching a proprietary AI model, positioning for future growth. Technical indicators show bullish momentum with the current price approaching key resistance levels.
The outlook remains positive with analyst consensus targeting $133.25 (29% upside), supported by recurring revenue strength and AI expansion. Risks include cybersecurity incidents and execution challenges in tech transformation. With 52% of analysts rating Buy and strong institutional interest, TRI presents a growth opportunity tempered by valuation concerns at current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
